Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8439218 | EBioMedicine | 2016 | 15 Pages |
Abstract
Smad3 deficiency leads to imbalanced activation of downstream genes, no activation of MMPs in VSMCs, and immune responses resulting in rapid aortic wall dilatation and rupture. Our findings uncover new possibilities for treatment of SMAD3 patients; instead of targeting TGF-β signaling, immune suppression may be more beneficial.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
I. PhD, N. BSc, J.H. PhD, J.L. PhD, Y. BSc, P.M. BSc, B.S. MSc, M. BSc, S.E. PhD, R.M.G.B. PhD, H.J.M. MD, PhD, R. PhD, A.M. MD, PhD, J. PhD,